Clinical Trial Update: Trial of Paclitaxel, Bevacizumab, and Enzastaurin Versus Paclitaxel, Bevacizumab and Placebo for Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing paclitaxel and bevacizumab with enzastaurin versus paclitaxel and bevacizumab with placebo for breast cancer has been terminated with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Enzastaurin (enzastaurin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2020-09-24